DOI: 10.1055/s-00000011

DMW - Deutsche Medizinische Wochenschrift


Kwo PY, Lawitz EJ, McCone J. et al.
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial. 
Lancet 2010; 376: 705-716  

Download Bibliographical Data

Search in: